Browsing: Biotech & Health

The absolute last chance to apply to host an official Side Event during TechCrunch Disrupt 2026 is tonight, September 11, at 11:59 p.m. PT.

Book your exhibit table at TechCrunch Disrupt 2026 by September 18 at 11:59 p.m. PT. Tables are limited and can sell out before the deadline.

Let’s just get this out of the way: Mark Wahlberg is as A-list as it gets. He broke out in 1997’s “Boogie Nights,” and in the nearly three decades since, he’s built one of the highest-wattage careers in Hollywood: two Academy Award nominations, a Golden Globe nod for “The Fighter,” multiple Emmy nominations as a…

The clock is almost out. You have less than 24 hours left to apply to host a Side Event during TechCrunch Disrupt 2026. Applications close tonight at midnight PT.

The filing with the Securities and Exchange Commission on Thursday shows that Oura’s revenue has jumped substantially in the past year. The company went from $697 million in revenue during the nine-month period that ended June 30 last year to $1.2 billion during the corresponding period this year.

Ultrahuman, an Indian startup best known for making smart rings, has raised $70 million in a new funding round that includes backing from Qualcomm’s venture arm, as it looks beyond sleep and health tracking to build a ring that can run software on the device and eventually power everything from AI interactions to games.

The Builders Stage is returning to TechCrunch Disrupt 2026, bringing together founders, startup operators, and investors for practical conversations on what it takes to build and scale successful companies.

It used to be that Vijay Pande was better known in academic circles than investor circles. That changed pretty abruptly a dozen years ago, when Marc Andreessen and Ben Horowitz — who’d spent their firm’s first five years explicitly avoiding healthcare and life sciences — decided the category was worth betting on after all and…

A cyberattack on U.S. medical device maker Boston Scientific is causing an ongoing “global disruption” to its operations, according to a federal regulatory filing on Wednesday, the latest healthtech giant to face a cyberattack in recent weeks.

Michael Polansky is remarkably unassuming for someone operating in a corner of the world known for outsize egos.